Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.00p -0.50% 1,597.60p 1,597.40p 1,597.80p 1,604.40p 1,594.60p 1,601.40p 281,375 08:32:17
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 30,821.0 4,048.0 73.7 21.7 -

GlaxoSmithKline PLC Result of AGM & GM

08/05/2019 6:23pm

UK Regulatory (RNS & others)


Glaxosmithkline (LSE:GSK)
Historical Stock Chart

2 Months : From Apr 2019 to Jun 2019

Click Here for more Glaxosmithkline Charts.

TIDMGSK

RNS Number : 4373Y

GlaxoSmithKline PLC

08 May 2019

GlaxoSmithKline plc

Result of Annual General Meeting and General Meeting

GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') and General Meeting today, all resolutions were passed by shareholders. The full text of the resolutions considered are contained in the 2019 Notice of AGM and the sole resolution of the General Meeting is contained in the Circular to Shareholders and Notice of General Meeting. These documents are available on the GSK website at www.gsk.com.

GSK AGM Poll Results

The following table shows the total number of votes cast for each resolution:

 
          Resolution              Total votes       %   Total votes       %     Total votes   Votes withheld(**) 
                                       for(*)               against                    cast 
      Receive and adopt 
       the 2018 Annual 
 1     Report                   3,556,826,649   99.95     1,863,433    0.05   3,558,690,082            7,283,024 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Approve the Annual 
 2     report on remuneration   3,157,857,593   88.77   399,443,579   11.23   3,557,301,172            8,672,905 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Election of Iain 
 3     Mackay                   3,509,580,387   98.56    51,394,236    1.44   3,560,974,623            4,999,291 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 4     Philip Hampton           3,523,220,874   98.94    37,814,132    1.06   3,561,035,006            4,939,054 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 5     Emma Walmsley            3,543,610,930   99.50    17,645,007    0.50   3,561,255,937            4,724,016 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 6     Vindi Banga              3,520,241,639   98.87    40,257,748    1.13   3,560,499,387            5,474,256 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 7     Dr Hal Barron            3,542,101,484   99.46    19,107,976    0.54   3,561,209,460            4,763,464 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 8     Dr Vivienne Cox          3,494,225,537   98.85    40,751,267    1.15   3,534,976,804           30,997,813 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 9     Lynn Elsenhans           3,543,230,972   99.50    17,848,986    0.50   3,561,079,958            4,893,685 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Election of Dr 
 10    Laurie Glimcher          3,543,924,853   99.52    17,255,115    0.48   3,561,179,968            4,793,241 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 11    Dr Jesse Goodman         3,543,465,739   99.50    17,643,172    0.50   3,561,108,911            4,864,732 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 12    Judy Lewent              3,513,131,684   98.66    47,693,254    1.34   3,560,824,938            5,154,954 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-election of 
 13    Urs Rohner               3,434,585,693   96.46   126,031,133    3.54   3,560,616,826            5,356,667 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Re-appointment 
 14    the auditor              3,557,236,743   99.88     4,327,420    0.12   3,561,564,163            4,412,192 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Remuneration of 
 15    auditor                  3,554,992,184   99.83     6,020,952    0.17   3,561,013,136            4,948,179 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Authority for the 
       company to make 
       donations to political 
       organisations and 
       incur political 
 16    expenditure              3,471,514,277   98.00    70,681,915    2.00   3,542,196,192           23,791,786 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Authority to allot 
 17    shares                   3,444,525,603   96.77   114,953,481    3.23   3,559,479,084            6,482,169 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Disapplication 
       of pre-emption 
       rights - general 
 18    power(***)               3,480,629,187   97.84    76,741,126    2.16   3,557,370,313            8,607,071 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Disapplication 
       of pre-emption 
       rights - in connection 
       with an acquisition 
       or specified capital 
 19    investment(***)          3,390,801,857   95.31   166,798,143    4.69   3,557,600,000            8,370,163 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Authority for the 
       company to purchase 
 20    its own shares(***)      3,509,141,893   98.57    50,794,321    1.43   3,559,936,214            6,028,543 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Exemption from 
       statement of senior 
       statutory auditor's 
 21    name                     3,524,087,916   99.51    17,395,554    0.49   3,541,483,470           24,488,266 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
      Authority for reduced 
       notice of a general 
       meeting other than 
 22    an AGM(***)              3,271,677,728   92.38   269,908,346    7.62   3,541,586,074           24,387,840 
     ------------------------  --------------  ------  ------------  ------  --------------  ------------------- 
 

GSK General Meeting Poll Results

The following table shows the total number of votes cast for the resolution:

 
           Resolution               Total votes       %   Total votes      %     Total votes   Votes withheld(**) 
                                         for(*)               against                   cast 
     To approve the transaction 
      between GlaxoSmithKline 
      plc, GlaxoSmithKline 
      Consumer Healthcare 
      Holdings Limited 
      and Pfizer, Inc for 
      the purposes of Chapter 
      11 of the Listing 
      Rules of the Financial 
 1    Conduct Authority           3,496,633,023   99.85    5,302,329    0.15   3,501,935,352           24,272,073 
    ---------------------------  --------------  ------  ------------  -----  --------------  ------------------- 
 
 

Notes:

 
 *     Includes discretionary votes. In line with the notification issued 
        to American Depositary Receipt (ADR) holders earlier this year, 
        GSK did not instruct its ADR Depositary to vote any unvoted ADRs 
        in respect of the resolutions for the 2019 AGM and GM 
 **    A vote withheld is not a vote in law and is not counted in the 
        calculation of the proportion of votes "For" or "Against" a resolution. 
 ***   Indicates Special Resolutions requiring a 75% majority. 
 

The above poll results will shortly be available on the Company's website at www.gsk.com. In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM

Simon Dingemans did not stand for re-election as a Director and retired from the Board with effect from the conclusion of the AGM.

In accordance with section 430(2B) of the Companies Act 2006, GSK confirms that Simon Dingemans will receive payment of fees for service whilst a Director, but no other remuneration payment or payment for loss of office will be made in connection with his departure.

The following table provides further relevant information:

 
 
                                                              GSK's           GSK's 
                                                         Nineteenth      Eighteenth 
                                                                AGM             AGM 
                                                             (2019)          (2018) 
 Issued share capital (excluding Treasury Shares)     4,987,806,108   4,959,302,644 
                                                     --------------  -------------- 
 Total votes cast and votes withheld lodged as 
  a % of GSK's issued share capital (excluding 
  Treasury Shares)                                           71.49%          78.76% 
                                                     --------------  -------------- 
 Total shareholder population                               108,698         112,326 
                                                     --------------  -------------- 
 Total number of proxies lodged                               6,635           6,931 
                                                     --------------  -------------- 
 % of shareholders who lodged proxies                         6.10%           6.17% 
                                                     --------------  -------------- 
 Number of shareholders, corporate representatives 
  and proxies who attended the AGM                              241             415 
                                                     --------------  -------------- 
 

V A Whyte

Company Secretary

8 May 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGUGUMGAUPBGMR

(END) Dow Jones Newswires

May 08, 2019 13:23 ET (17:23 GMT)

1 Year Glaxosmithkline Chart

1 Year Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

1 Month Glaxosmithkline Chart
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190626 07:47:31